Average difference in mean daily active calories in the week before and after the specified software transition, using different minimum data thresholds. حسب Shelby L. Sturrock (10751675)

الموضوعات:

Average difference in mean daily active calories in the week before and the week after transitioning between the indicated software versions. حسب Shelby L. Sturrock (10751675)

الموضوعات:

Difference in the number of LTSA between FY 2020 and FY 2019. حسب Yasuhiko Deguchi (3167955)

الموضوعات:

Participant characteristics, overall and for each transition, of primary analytic sample (activity data for all 14 days of the respective transition period). حسب Shelby L. Sturrock (10751675)

الموضوعات:

BMI curve for LSES. حسب Krystal Hunter (6820052)

الموضوعات:

BMI groups by SES. حسب Krystal Hunter (6820052)

الموضوعات:

BMISES_Data_Part2. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for LSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for HSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for overall population. حسب Krystal Hunter (6820052)

الموضوعات:

BMISES_Data_Part1. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of HSES/LSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of overall population. حسب Krystal Hunter (6820052)

الموضوعات:

Diagram of study population. حسب Krystal Hunter (6820052)

الموضوعات:

Schematic presentation <i>M</i>. <i>bovis</i> PG45 5′ nucleotidase and phylogenetic tree of its homologs. حسب Aga E. Gelgie (17661720)

الموضوعات:

<i>In vitro</i> characterization of the mnuA::Tn and 0690::Tn mutants. حسب Aga E. Gelgie (17661720)

الموضوعات:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Anthropometric, nutritional, and variable assessments of lean mass and fat mass obtained by DXA of exclusive breastfeeding mothers (EBF), at pre-pregnancy, baseline (15 days), and... حسب Larissa Brazolotto Ferreira (17671168)

الموضوعات:

Composition of different formulations with their responses in I optimal design for optimization of Axitinib loaded Spanlastics. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

The composition and validation of the optimized formula with its predicted responses according to I Optimal Design. حسب Randa Mohammed Zaki (21637175)

الموضوعات: